Circulating PCSK9 and Risk of Myocardial Infarction
The usefulness of circulating proprotein convertase subtilisin-kexin type 9 (PCSK9) as a risk marker of coronary heart disease in the general population remains unclear. In a nested case-control study in Norway, 1,488 incident myocardial infarctions were registered during 11.3 years of follow-up and...
Main Authors: | Lars E. Laugsand, MD, PhD, Bjørn O. Åsvold, MD, PhD, Lars J. Vatten, MD, PhD, Imre Janszky, MD, PhD, Carl G. Platou, MD, Annika E. Michelsen, PhD, Jan K. Damås, MD, PhD, Pål Aukrust, MD, PhD, Thor Ueland, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-12-01
|
Series: | JACC: Basic to Translational Science |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2452302X16300997 |
Similar Items
-
PCSK9 Modulates the Secretion But Not the Cellular Uptake of Lipoprotein(a) Ex Vivo
by: Elise F. Villard, PhD, et al.
Published: (2016-10-01) -
Validation of the Proposed cN2 Subclassification in the Eighth Edition of the IASLC Staging System: A Prospective Phase II Multicenter Study
by: Jiro Abe, MD, et al.
Published: (2020-06-01) -
Targeting IL-6 Trans-Signaling
by: Pål Aukrust, MD, PhD, et al.
Published: (2021-05-01) -
Long-term Prognosis and Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation: A Single-Center Experience
by: Yoshihide Ueda, MD, PhD, et al.
Published: (2017-12-01) -
Severe Antithrombin Deficiency May be Associated With a High Risk of Pathological Progression of DIC With Suppressed Fibrinolysis
by: Hideo Wada MD, PhD, et al.
Published: (2020-08-01)